Working… Menu
Trial record 2 of 2 for:    cannabinoids | Autism Spectrum Disorder

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03202303
Recruitment Status : Recruiting
First Posted : June 28, 2017
Last Update Posted : February 18, 2021
United States Department of Defense
GW Pharmaceuticals Ltd.
Information provided by (Responsible Party):
Eric Hollander, Montefiore Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : September 30, 2021